Stocks
Insight Molecular Diagnostics Inc.IMDX
NASDAQHealthcareDiagnostics & Research$2.89
Price as of · delayed, not real-time
A molecular diagnostics company offering testing services and products for infectious diseases and other health conditions. Its revenue streams and market position depend on regulatory approvals and reimbursement policies, making it a focus for investors tracking the diagnostics sector.
52W Range: $2.42-$8.51
Congressional Interest in Insight Molecular Diagnostics Inc. (IMDX)
No congressional trades have been disclosed for Insight Molecular Diagnostics Inc. (IMDX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IMDX?
No congressional trades found for this stock.